Massive thrombus burden with recurrence of intracoronary thrombosis early after stenting and delayed onset of prasugrel action in a patient with ST-elevation myocardial infarction and cardiac shock

Thrombosis and Haemostasis

Volumn 106, Issue 3, 2011, Pages 555-558

  Orban, Martin ^a   Byrne, Robert A ^a   Hausleiter, Jörg ^a   Laugwitz, Karl Ludwig ^a   Sibbing, Dirk ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CATECHOLAMINE DERIVATIVE; CLOPIDOGREL; HEPARIN; MORPHINE; PRASUGREL; PURINERGIC P2Y12 RECEPTOR;

ADULT; CARDIOGENIC SHOCK; CASE REPORT; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DEFIBRILLATION; DRUG MEGADOSE; FEMALE; HEART CATHETERIZATION; HEART VENTRICLE FIBRILLATION; HUMAN; INTENSIVE CARE; INTUBATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; LETTER; LOADING DRUG DOSE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RECURRENT DISEASE; RESUSCITATION; RETROSTERNAL PAIN; SEDATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; THROMBUS ASPIRATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOPULMONARY RESUSCITATION; CATECHOLAMINES; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY; FEMALE; HEART ARREST; HUMANS; MYOCARDIAL INFARCTION; PIPERAZINES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECURRENCE; STENTS; THIOPHENES; TICLOPIDINE; TIME FACTORS;

EID: 80052330469     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-04-0267     Document Type: Letter

References (14)

1. Sibbing D, Steinhubl SR, Schulz S, et al. Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window. J Am Coll Cardiol 2010; 56: 317-318
2. Williams CD, Cherala G, Serebruany V. Application of platelet function testing to the bedside. Thromb Haemost 2010; 103: 29-33
3. Bonello L, Tantry US, Marcucci R, et al. Consensus and future directions on the definition of high ontreatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 2010; 56: 919-933
4. Wiviott SD, Trenk D, Frelinger AL, et al. Prasugrel compared with high loading- and maintenancedose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation 2007; 116: 2923-2932
5. Sibbing D, Braun S, Morath T, et al. Platelet reactivity after clopidogrel treatment assessed with pointof- care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 2009; 53: 849-856
6. Sibbing D, Morath T, Braun S, et al. Clopidogrel response status assessed with Multiplate point-ofcare analysis and the incidence and timing of stent thrombosis over six months following coronary stenting. Thromb Haemost 2010; 103: 151-159
7. Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003; 107: 2908-2913
8. Jernberg T, Payne CD, Winters KJ, et al. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. Eur Heart J 2006; 27: 1166-1173
9. Jakubowski JA, Li YG, Small DS, et al. A comparison of the VerifyNow P2Y12 point-of-care device and light transmission aggregometry to monitor platelet function with prasugrel and clopidogrel: an integrated analysis. J Cardiovasc Pharmacol 2010; 56: 29-37
10. Neubauer H, Kaiser A, Busse B, et al. Identification, evaluation and treatment of prasugrel low-response after coronary stent implantation--a preliminary study. Thromb Res 2010; 126: e389-391
11. Montalescot G, Sideris G, Cohen R, et al. Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study. Thromb Haemost 2010; 103: 213-223
12. Montalescot G, Wiviott SD, Braunwald E, et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITONTIMI 38): double-blind, randomised controlled trial. Lancet 2009; 373: 723-731
13. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009; 361: 1045-1057
14. Osmancik P, Jirmar R, Hulikova K, et al. A comparison of the VASP index between patients with hemodynamically complicated and uncomplicated acute myocardial infarction. Catheter Cardiovasc Interv 2010; 75: 158-166.